Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
David Rosher King, M.D.
Internal Medicine · WASHINGTON, DC · NPI 1992746127
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 384 | 104 |
| Atorvastatin Calcium | Atorvastatin Calcium | 382 | 101 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 382 | 90 |
| Metoprolol Succinate | Metoprolol Succinate | 272 | 71 |
| Lisinopril | Lisinopril | 210 | 47 |
| Losartan Potassium | Losartan Potassium | 207 | 58 |
| Trulicity | Dulaglutide | 183 | 37 |
| Jardiance | Empagliflozin | 178 | 38 |
| Carvedilol | Carvedilol | 168 | 38 |
| Furosemide | Furosemide | 166 | 34 |
| Ozempic | Semaglutide | 160 | 20 |
| Chlorthalidone | Chlorthalidone | 159 | 37 |
| Gabapentin | Gabapentin | 152 | 47 |
| Eliquis | Apixaban | 143 | 23 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 133 | 24 |
| Famotidine | Famotidine | 128 | 30 |
| Metformin Hcl | Metformin Hcl | 126 | 32 |
| Mounjaro | Tirzepatide | 124 | 21 |
| Levothyroxine Sodium | Levothyroxine Sodium | 108 | 23 |
| Pantoprazole Sodium | Pantoprazole Sodium | 106 | 41 |
| Simvastatin | Simvastatin | 104 | 26 |
| Allopurinol | Allopurinol | 103 | 28 |
| Tamsulosin Hcl | Tamsulosin Hcl | 96 | 33 |
| Potassium Chloride | Potassium Chloride | 93 | 21 |
| Diclofenac Sodium | Diclofenac Sodium | 90 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 90 | 24 |
| Ezetimibe | Ezetimibe | 88 | 25 |
| Valsartan | Valsartan | 86 | 21 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 82 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 78 | 19 |
| Nifedipine Er | Nifedipine | 78 | 22 |
| Hydrochlorothiazide | Hydrochlorothiazide | 76 | 17 |
| Rybelsus | Semaglutide | 71 | 14 |
| Celecoxib | Celecoxib | 67 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 66 | 18 |
| Spironolactone | Spironolactone | 66 | 12 |
| Methylprednisolone | Methylprednisolone | 63 | 43 |
| Trazodone Hcl | Trazodone Hcl | 60 | 14 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 58 | 18 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 55 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 52 | 16 |
| Alendronate Sodium | Alendronate Sodium | 51 | 17 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 50 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 49 | 12 |
| Symbicort | Budesonide/Formoterol Fumarate | 48 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 47 | 16 |
| Januvia | Sitagliptin Phosphate | 46 | 14 |
| Meclizine Hcl | Meclizine Hcl | 46 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 46 | 18 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 44 | suppressed |
| Glimepiride | Glimepiride | 43 | 11 |
| Myrbetriq | Mirabegron | 43 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 42 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 42 | suppressed |
| Lubiprostone | Lubiprostone | 41 | suppressed |
| Xarelto | Rivaroxaban | 41 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 39 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 36 | suppressed |
| Telmisartan | Telmisartan | 36 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 35 | 13 |
| Labetalol Hcl | Labetalol Hcl | 35 | suppressed |
| Ibuprofen | Ibuprofen | 34 | suppressed |
| Omeprazole | Omeprazole | 34 | suppressed |
| Sucralfate | Sucralfate | 34 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 34 | 14 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 34 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 32 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 30 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 30 | suppressed |
| Meloxicam | Meloxicam | 30 | suppressed |
| Pregabalin | Pregabalin | 30 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 29 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 28 | suppressed |
| Testosterone | Testosterone | 28 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 27 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 27 | suppressed |
| Entresto | Sacubitril/Valsartan | 26 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 26 | suppressed |
| Linzess | Linaclotide | 25 | 11 |
| Trijardy Xr | Empaglifloz/Linaglip/Metformin | 25 | suppressed |
| Azelastine-Fluticasone | Azelastine/Fluticasone | 24 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 24 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 24 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 24 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 22 | suppressed |
| Lidocaine | Lidocaine | 22 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 22 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 21 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 21 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 20 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 20 | suppressed |
| Clonidine | Clonidine | 19 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 19 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 19 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 18 | suppressed |
| Carbamazepine | Carbamazepine | 18 | suppressed |
| Levemir Flexpen | Insulin Detemir | 18 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 17 | suppressed |
| Fluocinonide | Fluocinonide | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 17 | suppressed |
| Irbesartan | Irbesartan | 16 | suppressed |
| Naproxen | Naproxen | 16 | suppressed |
| Ondansetron Odt | Ondansetron | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Humalog Kwikpen U-200 | Insulin Lispro | 15 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 14 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 14 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 14 | suppressed |
| Premarin | Estrogens, Conjugated | 14 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Repaglinide | Repaglinide | 13 | suppressed |
| Repatha Syringe | Evolocumab | 13 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Isosorbide Dinit-Hydralazine | Isosorbide Dinit/Hydralazine | 12 | suppressed |
| Lorazepam | Lorazepam | 12 | suppressed |
| Memantine Hcl | Memantine Hcl | 12 | suppressed |
| Mirtazapine | Mirtazapine | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Lactulose | Lactulose | 11 | suppressed |
| Levetiracetam | Levetiracetam | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Pen Needles | Pen Needle, Diabetic | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error